Jubilant Pharmova Ltd.

View in App
335.45 +5.30 ▲1.6%

02 June 2023, 04:01:00 PM
Volume: 5,784

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jubilantpharmova.com
Market Cap 5,340.70 Cr.
Enterprise Value(EV) 7,736.48 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -3.83 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 338.98 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.99 Calculated using Price: 335.45
Dividend Yield 1.49 Period Ending 2022-03
No. of Shares Subscribed 15.93 Cr. 159,281,139 Shares
FaceValue 1
About Jubilant Pharmova Ltd.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients, drug discovery solutions and India branded pharmaceuticals. Jubilant Pharma Limited, is engaged in manufacturing and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six USFDA approved manufacturing facilities in the US, Canada and India and a network of various radiopharmacies in the US.

Jubilant Pharmova Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Jubilant Pharmova Ltd. Performance

View details >>
1 Day
+1.61%
1 Week
-7.53%
1 Month
+7.45%
3 Month
+9.53%
6 Month
-11.48%
1 Year
-14.73%
2 Year
-60.54%
5 Year
-56.38%
10 Year
+115.45%

Jubilant Pharmova Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.39 -1.58 14.27 17.95 16.87 12.97 13.02 11.09 8.21
Return on Capital Employed (%) 7.92 5.72 12.42 14.44 15.21 13.06 12.20 12.02 9.97
Return on Assets (%) 1.60 -0.46 4.46 6.52 6.91 5.55 5.74 5.45 4.44

Jubilant Pharmova Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 2,627 2,454 2,966 3,436 4,087 4,809 5,604 4,741 5,319 5,399
Non Curr. Liab. 2,185 4,036 3,347 3,826 3,417 4,420 4,088 2,973 2,922 3,765
Curr. Liab. 3,894 2,129 2,464 1,684 2,005 2,090 2,619 1,049 1,592 1,772
Minority Int. 158 -38 -47 -52 0 0 -2 -7
Equity & Liab. 8,864 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,929
Non Curr. Assets 5,936 5,904 5,864 5,951 6,267 6,734 7,272 5,811 6,320 7,167
Curr. Assets 2,928 2,715 2,875 2,948 3,190 4,585 5,038 2,953 3,509 3,762
Misc. Exp. not W/O
Total Assets 8,864 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,929

Jubilant Pharmova Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 5,803 5,826 5,749 5,861 7,518 9,111 5,976 6,099 6,130 6,282
Other Income 19 42 13 25 40 36 37 18 11 38
Total Income 5,822 5,869 5,763 5,886 7,558 9,147 6,013 6,116 6,141 6,320
Total Expenditure -4,782 -5,125 -4,502 -4,516 -5,999 -7,372 -4,428 -4,702 -4,974 -5,505
PBIDT 1,040 744 1,260 1,370 1,558 1,775 1,585 1,414 1,168 815
Interest -337 -368 -371 -341 -284 -220 -200 -184 -145 -188
Depreciation -281 -288 -347 -291 -415 -371 -340 -349 -382 -554
Taxation -70 -80 -155 -163 -225 -327 -335 -297 -217 -93
Exceptional Items -214 -48 -280 -33 -21 -57
PAT 138 -40 387 575 634 577 678 574 413 -77
Minority Interest -29 -18 5 1 8 -3 0 1 4
Share Associate 12
Other Related Items
Consolidated Net Profit 109 -58 392 576 643 574 898 836 414 -61
Adjusted EPS 7 -4 25 37 41 36 56 53 26 -4

Jubilant Pharmova Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 970 772 783 1,099 1,268 1,303 1,122 1,543 1,784 838
Cash Fr. Inv. -500 -174 -343 -313 -450 -618 -1,012 -327 -739 -380
Cash Fr. Finan. -450 -414 -503 -843 -686 -901 657 -1,050 -1,709 -33
Net Change 20 183 -63 -56 132 -216 767 166 -664 425
Cash & Cash Eqvt 280 473 392 339 456 244 1,005 1,231 502 984

Jubilant Pharmova Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68
Public 49.32 49.32 49.33 49.32 49.32 49.32 49.32 49.32 49.32
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Jubilant Pharmova Ltd. Announcements

View details >>
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose copies of the Audited Standalone and Consolidated Financial Statement of the Company for the quarter and Financial Year ended March 31 2023 published on May 30 2023 in MINT (English) and HINDUSTAN (Hindi).
Tue, 30 May 2023
Investor Meet
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the management of the Company shall be attending Group Meeting on May 30 2023. We enclose details of the Investors/ Analysts for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company.
Tue, 30 May 2023
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
We enclose disclosure pertaning to resignation of CFO and Appointment of new CFO

Jubilant Pharmova Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
Close Below Last Week Low Close Below Last Week Low
High Increase in 1 Month High Increase in 1 Month
High Decrease in 2 Years High Decrease in 2 Years

Jubilant Pharmova Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 999.35 +1.2%
Divi's Laboratories Ltd. 93,340.08 3,539.90 +0.4%
Cipla Ltd. 77,917.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. 60,134.99 1,774.00 -0.1%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%

Jubilant Pharmova Ltd. FAQ's

What is Jubilant Pharmova share price?
Can I buy Jubilant Pharmova shares now?
What is the Dividend Yield of Jubilant Pharmova?
What is the Market Cap of Jubilant Pharmova?
What are the key metrics to analyse Jubilant Pharmova?
What is the 52 Week High and Low of Jubilant Pharmova?
What is the trend of Jubilant Pharmova share price?